Treatment of children with HBeAg-positive chronic hepatitis B: A systematic review and meta-analysis

Digestive and Liver Disease

Volumn 46, Issue 12, 2014, Pages 1103-1110

  El Sherbini, Azza ^a   Omar, Asmaa ^b  

^a Tanta Fever Hospital   (Egypt)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Children; Chronic hepatitis B; Meta analysis; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA TOCOPHEROL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LEVAMISOLE; LIVER ENZYME; PREDNISONE; VIRUS DNA; ANTIVIRUS AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BEHAVIOR DISORDER; CHRONIC HEPATITIS B; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONVULSION; DATA BASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPISTAXIS; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; INFECTION; LEUKOPENIA; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; SEROCONVERSION; SIDE EFFECT; SYSTEMATIC REVIEW; THYROID DISEASE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; WEIGHT REDUCTION; CHILD; DRUG COMBINATION; HEPATITIS B, CHRONIC; STATISTICAL MODEL; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; CHILD; DRUG THERAPY, COMBINATION; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MODELS, STATISTICAL; TREATMENT OUTCOME;

EID: 84930484047     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.08.032     Document Type: Article

References (57)

1. World Health Organization. Hepatitis B. Fact sheet no. 204. Available at: [accessed 08.10.13]. http://www.who.int/mediacenter/factsheets/fs204/en/.
2. Hoofnagle J.H., Di Bisceglie A.M. The treatment of chronic viral hepatitis. New England Journal of Medicine 1997, 336:347-356.
3. Ruiz-Moreno M., Rua M.J., Molina J., et al. Prospective, randomized controlled trial of interferon α in children with chronic hepatitis B. Hepatology 1991, 13:1035-1039.
4. Jonas M.M., Kelley D.A., Mizerski J., et al. Clinical trial of lamivudine in children with chronic hepatitis B. New England Journal of Medicine 2002, 346:1706-1713.
5. Gilead Sciences. Liver disease, marketed products. Available at: [last updated August 2013/accessed 08.10.13]. http://www.gilead.com/.
6. Sokal E.M., Paganelli M., Wirth S., et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines. Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Hepatology 2013, 59:814-829.
7. Jonas M.M., Block J.M., Haber B.A., et al. Treatment of children with chronic hepatitis B virus infection in the United States: patients selection and therapeutic options. Hepatology 2010, 52:2192-2205.
8. Haber B.A., Block J.M., Jonas M.M., et al. Recommendations for screening, monitoring and referral of pediatric chronic hepatitis B. Pediatrics 2009, 124:e1007-e1013.
9. Pawlowska M., Halota W., Smukalska E., et al. HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B. European Journal of Clinical Microbiology and Infectious Diseases 2012, 31:571-574.
10. Yeung L.T., King S.M., Roberts E.A. Mother-to-infant transmission of hepatitis C virus. Hepatology 2001, 34:223-229.
11. Higgins J.P.T., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analysis. British Medical Journal 2003, 237:557-560.
12. Bruguera M., Amat L., Garcia O., et al. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection. Journal of Clinical Gastroenterology 1993, 17:296-299.
13. Narkewicz M.R., Smith D., Silverman A., et al. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment. Journal of Pediatrics 1995, 127:815-818.
14. Gürakan F., Kocak N., Ozen H., et al. Comparison of standard and high dosage recombinant alpha 2b for treatment of children with chronic hepatitis B infection. Pediatric Infectious Disease Journal 2000, 19:52-56.
15. Ertem D., Acar Y., Karaa E.K., et al. High-dose interferon results in high HBsAg sero-clearance in children with chronic hepatitis B infection. Turkish Journal of Pediatrics 2003, 45:123-128.
16. Kobak G.E., Mackenzie T., Sokol R.J., et al. Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger. Journal of Pediatrics 2004, 145:340-345.
17. Barbera C., Bortolotti F., Crivellaro C., et al. Recombinant interferon-alfa2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 1994, 20:287-290.
18. Vajro P., Tedesco M., Fontanella A., et al. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatric Infectious Disease Journal 1996, 15:223-231.
19. Sokal E.M., Conjeevaram H.S., Roberts E.A., et al. Interferon Alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 1998, 114:988-995.
20. Hsu H.Y., Tsai H.Y., Wu T.C., et al. Interferon-α treatment in children and young adults with chronic hepatitis B: a long-term follow up study in Taiwan. Liver International 2008, 28:1288-1297.
21. Dikici B., Bosnak M., Kara H.I., et al. Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection. Pediatric Infectious Disease Journal 2001, 20:988-992.
22. Dikici B., Bosnak M., Bosnak V., et al. Combination therapy for children with chronic hepatitis B virus infection. Journal of Gastroenterology and Hepatology 2002, 17:1087-1091.
23. Dikici B., Ozgenc F., Kalayci A.G., et al. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. Journal of Gastroenterology and Hepatology 2004, 19:127-133.
24. Kansu A., Doganci T., Akman S.A., et al. Comparison of two different regimens of combined interferon-α2a and lamivudine therapy in children with chronic hepatitis B infection. Antiviral Therapy 2006, 11:255-261.
25. D'Antiga L., Aw M., Atkins M., et al. Combined Lamivudine/interferon-α treatment in immunotolerant children perinatally infected with hepatitis B: a pilot study. Journal of Pediatrics 2006, 148:228-233.
26. Yilmaz A., Akcam M., Gelen T., et al. Lamivudine and high-dose interferon alpha 2a combination treatment in naïve HBeAg-positive immunoactive chronic hepatitis B in children: an East Mediterranean center's experience. European Journal of Pediatrics 2007, 166:195-199.
27. Ruiz-Moreno M., Garcia R., Rua M.J., et al. Levamisole and interferon in children with chronic hepatitis B. Hepatology 1993, 18:264-269.
28. Helvaci M., Kizilgunesler A., Kasirga E., et al. Efficacy of hepatitis B vaccination and interferon-α-2b monotherapy in children with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2004, 19:785-791.
29. Utili R., Sagnelli E., Gaeta G.B., et al. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study. Journal of Hepatology 1994, 20:163-167.
30. Dikici B., Kalayci A.G., Ozgenc F., et al. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection. Pediatric Infectious Disease Journal 2003, 22:345-349.
31. Gerner P., Posselt H.G., Krahl A., et al. Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial. World Journal of Gastroenterology 2008, 14:7208-7213.
32. Ni Y.H., Huang F.C., Wu T.C., et al. Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients. Pediatrics International 2005, 47:372-377.
33. Sokal E.M., Kelly D.A., Mizerski J., et al. Long-term Lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006, 43:225-232.
34. Jonas M.M., Little N.R., Gardner S.D., et al. Long-term Lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety. Journal of Viral Hepatitis 2008, 15:20-27.
35. Jonas M.M., Kelly D., Pollack H., et al. Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2-to-<18 years) with chronic hepatitis B. Hepatology 2008, 47:1863-1871.
36. Murray K.F., Szenborn L., Wysocki J., et al. Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B. Hepatology 2012, 56:2018-2026.
37. Lin Z.Q., Fang F., Guo Z.P., et al. Effect of interferon-alpha treatment in children with hepatitis B e antigen positive chronic hepatitis B virus infection: a meta-analysis of follow up for six months to two years. Zhonghua Er Ke Za Zhi 2007, 45:592-598.
38. Torre D., Tambini R. Interferon-α therapy for chronic hepatitis B in children: a meta-analysis. Clinical Infectious Diseases 1996, 23:131-137.
39. Vajro P., Migliaro F., Fontanella A., et al. Interferon: a meta-analysis of published studies in Pediatric chronic hepatitis B. Acta Gastroenterologica Belgica 1998, 61:219-223.
40. Shen Y.C., Hsu C., Cheng C.C., et al. A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression. Oncology 2012, 82:275-289.
41. Tine F., Liberati A., Craxi A., et al. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. Journal of Hepatology 1993, 18:154-162.
42. Wong O.K., Cheung A.M., O'Rourke K., et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Annals of Internal Medicine 1993, 119:312-323.
43. Bortolotti F., Jara P., Barbera C., et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000, 46:715-718.
44. Iorio R., Giannattasio A., Cirillo F., et al. Long-term outcome in children with chronic hepatitis B: a 24 year observation period. Clinical Infectious Diseases 2007, 45:943-949.
45. Diem H.V.T., Bourgois A., Bontems P., et al. Chronic hepatitis B infection: long term comparison of children receiving interferon Alpha and untreated controls. Journal of Pediatric Gastroenterology & Nutrition 2005, 40:141-145.
46. Boxall E., Sira J., Kaskar S., et al. Does genotype predict response to treatment in children infected with hepatitis B perinatally. Journal of Medical Virology 2012, 84:1535-1540.
47. Shamliyan T.A., MacDonald R., Shaukat A., et al. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institute of Health consensus development conference. Annals of Internal Medicine 2009, 150:111-124.
48. Lok A.S., Wu P.C., Lai C.L., et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992, 102:2091-2097.
49. Mowat A.P. Liver disorders in childhood. Viral infections of the liver 1994, 103-113. Butterworth-Heinemann Ltd, Oxford. third ed.
50. De Franchis R., Hadengue A., Lau G.K., et al. EASL international consensus conference on hepatitis B. Journal of Hepatology 2003, 38:533-540.
51. Jones J., Shepherd J., Baxter L., et al. Adefovir dipioxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation. Health Technology Assessment 2009, 13:1-172.
52. Woo G., Tomlinson G., Nishikawa Y., et al. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analysis. Gastroenterology 2010, 139:1218-1229.
53. Chang T.T., Lai C.L., Kew Yoon S., et al. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2010, 51:422-430.
54. Andreone P., Fiorino S., Cursaro C., et al. Vitamin E as treatment for chronic hepatitis B: results of randomized controlled pilot trial. Antiviral Research 2001, 49:75-81.
55. Michel M.L., Pol S., Brechot C., et al. Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future. Vaccine 2001, 19:2395-2399.
56. Conjeevaram H.S., Lok A.S. Management of chronic hepatitis B. Journal of Hepatology 2003, 38(Suppl. 1):S90. 103.
57. Chadwick R.G., Jain S., Cohen B.J., et al. Levamisole therapy for HBsAg-positive chronic liver disease. Scandinavian Journal of Gastroenterology 1980, 15:973-978.